Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma

समान संसाधन

• Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma
  द्वारा: Tucci, Marco, और अन्य
  प्रकाशित: (2017)
• Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
  द्वारा: Tallerico, Rossana, और अन्य
  प्रकाशित: (2015)
• PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab
  द्वारा: Madonna, Gabriele, और अन्य
  प्रकाशित: (2018)
• Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
  द्वारा: Ascierto, Paolo A, और अन्य
  प्रकाशित: (2012)
• Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
  द्वारा: Tucci, Marco, और अन्य
  प्रकाशित: (2018)